Viewing Study NCT01440595


Ignite Creation Date: 2025-12-24 @ 1:28 PM
Ignite Modification Date: 2025-12-31 @ 3:59 AM
Study NCT ID: NCT01440595
Status: TERMINATED
Last Update Posted: 2024-05-22
First Post: 2011-09-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012)
Sponsor: Merck Sharp & Dohme LLC
Organization: